Menu
US
future-of-immunotherapy-with-base-editing-literature-review1920x640
Whitepaper

Base editing and stem-cell based therapies

For years iPSCs have been the subject of intense research efforts with recent advances with gene editing technologies. Discover how base editing is pushing this further in the fields of basic science, regenerative medicine and immunotherapy.

In this white paper, you will learn about…

  • An overview of induced pluripotent stem cells (iPSCs)
  • How gene editing has been applied to iPSCs

How base editing can help to unlock the full potential of iPSCs for immunotherapies

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Base editing and stem-cell based therapies

Download Whitepaper